Search

everythinglearnresearchcommunity

for

Search:↓

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.